J Melville Engle is of Predictive Oncology Inc.. Currently has a direct ownership of 416,693 shares of POAI, which is worth approximately $308,352. The most recent transaction as insider was on Nov 01, 2022, when has been sold 213,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 417K
0% 3M change
0% 12M change
Total Value Held $308,352

J MELVILLE ENGLE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2022
BUY
Grant, award, or other acquisition
-
213,300 Added 33.86%
416,693 Common Stock
May 24 2022
BUY
Open market or private purchase
$59,015 $0.37 p/Share
159,500 Added 43.95%
203,393 Common Stock
Jan 04 2022
BUY
Grant, award, or other acquisition
-
20,428 Added 31.76%
43,893 Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
-
4,512 Added 16.13%
23,465 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
-
9,924 Added 34.37%
18,953 Common Stock
Apr 01 2021
BUY
Grant, award, or other acquisition
-
4,959 Added 35.45%
9,029 Common Stock
JME

J Melville Engle

Thornton, CO

Track Institutional and Insider Activities on POAI

Follow Predictive Oncology Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells POAI shares.

Notify only if

Insider Trading

Get notified when an Predictive Oncology Inc. insider buys or sells POAI shares.

Notify only if

News

Receive news related to Predictive Oncology Inc.

Track Activities on POAI